• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Managed Care Cast Presents: Stakeholders Summit—Biosimilars in Inflammatory Diseases, Part 1

Commentary
Podcast

In part 1 of this 2-part podcast, a panel of experts discusses the clinical manifestations of inflammatory diseases and the potential for biosimilars to treat these diseases.

Today we are bringing you part 1 of a 2-part sponsored podcast series discussing the use of biosimilars in inflammatory diseases. The discussion was moderated by Ryan Haumschild, PharmD, director of Pharmacy Services at Emory Healthcare and Winship Cancer Institute.

The conversation for today’s podcast includes the clinical manifestation of inflammatory diseases, comorbid conditions, and the role of biologics and biosimilars in disease management.

Listen above or through one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

Related Videos
Eneline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA
© 2024 MJH Life Sciences
AJMC®
All rights reserved.